Inventor · disambiguated record
Samuel Clark
Also filed as: CLARK SAMUEL · CLARK SAMUEL H
11 granted patents·26 pending applications·13 citations·filing 1975–2024
84Inventor score
Files withTERRAN BIOSCIENCES INC34HAN SANG EON1RAYMOND LEE ORGANIZATION INC1UNIV OF OTTAWA INSTITUTE OF MENTAL HEALTH RESEARCH1
Top patents by PatentIndex Score
37 records- 0190US11958821B2Phenethylamine compounds salts, polymorphic forms and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Granted Apr 16, 2024·2 cites·25 claims
- 0279US12435036B2Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-n,n-dimethylpropan-2-amineTERRAN BIOSCIENCES INC·Filed 2024·Granted Oct 7, 2025·0 cites·14 claims
- 0379US12079960B2Systems, devices, and methods for harmonization of imaging datasets including biomarkersTERRAN BIOSCIENCES INC·Filed 2022·Granted Sep 3, 2024·2 cites·18 claims
- 0479US2024409526A1Phenethylamine compounds salts, polymorphic forms and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0578US11945832B2Psilocybin and O-acetylpsilocin, salts and solid state forms thereofTERRAN BIOSCIENCES INC·Filed 2023·Granted Apr 2, 2024·0 cites·18 claims
- 0675US12319652B2Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amineTERRAN BIOSCIENCES INC·Filed 2023·Granted Jun 3, 2025·0 cites·30 claims
- 0775US12234216B2Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2022·Granted Feb 25, 2025·0 cites·14 claims
- 0875US11851452B2Psilocybin and O-acetylpsilocin, salts and solid state forms thereofTERRAN BIOSCIENCES INC·Filed 2022·Granted Dec 26, 2023·0 cites·28 claims
- 0975US9246031B1Supressing optical loss in nanostructured metals by increasing self-inductance and electron path lengthHAN SANG EON·Filed 2014·Granted Jan 26, 2016·2 cites·17 claims
- 1075US2023202998A1Phenethylamine compounds salts, polymorphic forms and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1173US12269818B2Analogs of xanomelineTERRAN BIOSCIENCES INC·Filed 2024·Granted Apr 8, 2025·0 cites·42 claims
- 1272US2024002337A1Salts and solid forms of (r)-1-(5-methoxy-1h-indol-1-yl)-n,n-dimethylpropan-2-amineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1372US2025011351A1Psilocybin and o-acetylpsilocin, salts and solid state forms thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1471US11905295B2Solid forms of tabernanthalog monofumarate salt for treating neurological disorders and/or psychiatric disordersTERRAN BIOSCIENCES INC·Filed 2023·Granted Feb 20, 2024·0 cites·28 claims
- 1568US2023159456A1N-substituted indolesTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1668US2025066299A1Salts and solid forms of 4-hydroxy-n,n-diisopropyltryptamine hemi-glutarate and hemi-succinateTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1767US2023150965A1Isotopically enriched n-methyl-1,3-benzodioxolylbutanamine (mbdb) and stereoisomers thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1867US2023257385A1Salt and solid forms of tabernanthalogTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1966US2025109130A1Isotopically enriched analogs of 2-bromo-lsd, lsd, ald-52, and 1p-lsdTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2066US2024400512A1Analogs of n,n,n-trimethyl-4-phosphoryloxytryptamineTERRAN BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2166US2025034105A1Isotopically enriched n-methyl-1,3-benzodioxolylbutanamine (mbdb) and stereoisomers thereofTERRAN BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2265US2023181521A1Isotopically enriched analogs of 5,6-methylenedioxy-2-aminoindane (mdai)TERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2365US2024294488A1Isotopologes, salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2465US2023150936A1Analogs of n,n,n-trimethyl-4-phosphoryloxytryptamineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2561US2023159544A1Azepino-indoles for the treatment of neurological and psychiatric disordersTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2661US2025091993A1Salts and solid forms of n-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amineTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2760US2025129064A1Prodrugs of 2-bromo-lsd (2-bromolysergic acid diethylamide)TERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2860US2025195477A1Deuterated idazoxan and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2960US2025136548A1Functionalized alkylaminesTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3059US2025129054A1Prodrugs of 3,4-methylenedioxy-n-methcathinone and uses thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3159US2025049748A1Analogs of 4-bromo-2,5-dimethoxyphenethylamineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3259US2023150966A1Isotopically enriched 3,4-methylenedioxy-n-ethylamphetamine (mde) and stereoisomers thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3352US2025344963A1Methods for acquiring and analyzing neuromelanin-sensitive mriUNIV OF OTTAWA INSTITUTE OF MENTAL HEALTH RESEARCH·Filed 2023·Application pending·0 cites
- 3450US3978929ARotor tiller with attachment thereforRAYMOND LEE ORGANIZATION INC·Filed 1975·Granted Sep 7, 1976·7 cites·4 claims
- 3550US2023150920A1Salts and solid forms of 4-bromo-2,5-dimethoxyphenethylamineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3645US2022273184A1Neuromelanin-sensitive mri for assessing parkinson's diseaseTERRAN BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 3745US2023389854A1Neuromelanin-sensitive mri and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Samuel Clark files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →